≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Seminoma of testis, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_TESTIS_SEMINOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C62.01&, C62.11&, C62.91&
  • Hospital discharge: ICD-9 — 186A
  • Cause of death: ICD-10 — C62.01&, C62.11&, C62.91&
  • Cause of death: ICD-9 — 186A
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — 9061
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

362

4. Check minimum number of events

None

362

5. Include endpoints

None

362

6. Filter based on genotype QC (FinnGen only)

362

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Seminoma of testis, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 362 - 362
Unadjusted period prevalence (%) 0.16 - 0.16
Median age at first event (years) 37.93 - 37.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
328
Matched controls
3280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
309.6
246
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
3434.6
271.0
224
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
264.9
217
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
560.8
200.3
180
7
JN4BD
NOMESCO Finland
Extensive body CT
30.6
99.3
137
75
130
Kela drug reimbursment
Malignant tumour
+∞
99.1
90
*
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
63.6
59
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
62.5
58
*
A03FA01
ATC
metoclopramide; systemic, rectal
16.0
62.2
107
96
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
25.7
61.9
88
46
JN4AD
NOMESCO Finland
Body CT examination
29.6
56.0
76
33
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
49.2
46
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
+∞
44.8
42
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
41.5
39
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
40.5
38
*
A04AA02
ATC
granisetron; systemic, transdermal
424.4
38.9
38
*
H02AB02
ATC
dexamethasone; systemic
50.6
37.0
44
10
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
36.1
34
*
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
33.9
32
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
189.0
33.4
34
*
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
31.8
30
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
31.8
30
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
7.5
30.3
77
129
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.9
30.0
187
825
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
29.6
28
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
29.6
28
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
28.8
138
479
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
26.4
25
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
25.3
24
*
L03AA02
ATC
filgrastim; parenteral
269.7
25.0
25
*
JN3AD
NOMESCO Finland
Abdominal CT examination
8.4
24.0
55
77
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
23.2
22
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
20.9
23.1
34
18
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
22.1
21
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
18.9
18
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
17.9
17
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
17.9
17
*
A04AA01
ATC
ondansetron; systemic, rectal
20.0
17.6
26
14
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
17.1
106
421
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
67.0
16.9
19
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
178.7
16.7
17
*
N02AA05
ATC
oxycodone; systemic
5.0
16.0
54
125
WF002
NOMESCO Finland
Radical radiotherapy
89.5
15.7
17
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
84.0
14.7
16
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
14.7
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.7
14
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
13.6
63
197
D70.82
ICD-10 Finland
Drug-induced neutropenia
145.8
13.6
14
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
145.8
13.6
14
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.0
13.1
55
157
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
12.6
12
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
12.6
12
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
12.6
12
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
12.6
12
*
ZXE00
NOMESCO Finland
One hour or less
2.5
12.3
126
656
E29.1
ICD-10 Finland
Testicular hypofunction
7.6
11.8
27
38
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
11.5
11
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
11.5
11
*
WZC30
NOMESCO Finland
Teaching
3.8
10.9
48
143
WX320
NOMESCO Finland
Spinalanesthesy
2.8
10.8
75
311
N02BE01
ATC
paracetamol; systemic, rectal
2.4
10.5
263
2048
L03AA13
ATC
pegfilgrastim; parenteral
+∞
10.5
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.5
10
*
Y78
ICPC
Malign neopl male genital other
+∞
10.5
10
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
10.5
10
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
10.5
10
*
WW500
NOMESCO Finland
Blood transfusion
11.1
10.4
19
18
N46
ICD-10 Finland
Male infertility
6.2
10.2
27
47
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.8
9.7
42
123
JN4CD
NOMESCO Finland
Very extensive body CT
9.5
9.7
19
21
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
102.9
9.5
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
9.4
111
604
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
9.4
9
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.1
9.3
22
33
XX3DW
NOMESCO Finland
Time consuming IT work
5.2
8.7
26
53
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
8.6
21
33
ZX120
NOMESCO Finland
Intravenous
3.9
8.6
35
98
7513
FHL
Test prosthesis installation
92.3
8.5
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
8.4
61
256
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
8.4
8
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
+∞
8.4
8
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
8.4
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.4
8
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
9.8
7.9
15
16
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
7.8
109
629
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
81.9
7.4
8
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
81.9
7.4
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.4
7.4
21
41
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.0
7.3
19
33
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
WX402
NOMESCO Finland
General anaesthesia
2.7
7.3
52
216
KFA00
NOMESCO Finland
Exploration of testis
16.2
7.3
11
7
R50.9
ICD-10 Finland
Fever, unspecified
2.7
7.2
49
200
B01AB05
ATC
enoxaparin; parenteral
2.2
6.9
75
386
B01AB10
ATC
tinzaparin; parenteral
5.4
6.7
19
37
Z51.5
ICD-10 Finland
Palliative care
8.1
6.7
14
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
6.7
27
76
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
6.3
6
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.2
6.1
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
183
29
126.59
307.65
7.8
2.4
u/ml
86.4
2.8
0.50
175
29
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
197
9
471.03
217.08
8.9
1.3
u/l
16.8
—
—
54
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
78
35
28.13
109.60
3.6
1.5
iu/l
16.7
7.1
3.44
69
25
(3009214) Lutropin [Units/volume] in Serum or Plasma
106
108
13.46
97.49
3.1
1.5
u/l
7.3
4.1
3.37
94
94
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
94
6
210.61
94.28
9.5
1.3
—
—
—
0
0
(4035726)
75
70
13.25
72.06
1.2
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
153
498
4.59
43.26
4.3
2.4
nmol/l
13.5
15.8
3.74
148
463
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
299
1910
4.25
26.63
12.0
5.8
u/l
76.4
74.1
0.62
294
1803
(40768804) Tissue Pathology biopsy report
148
659
3.11
23.55
2.3
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
84
270
3.75
22.55
1.3
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
39
67
6.40
22.31
1.5
3.2
g/l
3.8
3.8
0.01
39
67
(3013650) Neutrophils [#/volume] in Blood by Automated count
236
1401
2.97
21.57
11.9
7.5
e9/l
3.6
4.3
5.43
212
1243
(3002256) Pathology report gross observation
65
189
3.97
20.02
1.3
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
135
630
2.82
19.00
5.5
2.0
mmol/l
2.4
2.3
0.73
124
550
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
43
98
4.84
18.07
6.4
1.9
ug/l
4.1
5.4
0.18
36
79
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
6
38.89
17.82
6.4
3.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
126
590
2.74
17.37
3.7
2.6
e6/l
0.6
0.3
0.35
101
442
(3002582) Erythrocytes [#/volume] in Urine
135
658
2.68
17.15
3.8
2.6
e6/l
99.1
139.4
0.13
107
513
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
84
321
3.11
16.77
5.8
1.9
mmol/l
2.4
2.4
0.73
74
267
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
165
916
2.47
15.65
4.0
3.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
93
393
2.84
15.39
1.7
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
149
797
2.48
15.24
3.9
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
148
791
2.47
15.15
6.4
6.0
—
—
—
0
0
(3036489) Thrombin time
36
82
4.76
15.09
1.5
2.5
s
21.0
20.9
0.08
36
74
(3018095) Leukocytes [#/volume] in Urine
142
746
2.49
15.07
4.3
3.0
e6/l
132.2
123.6
0.04
110
545
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
83
334
2.93
15.00
3.6
2.5
e6/l
0.4
0.5
0.32
54
181
(40758558) Short blood count panel - Blood
116
562
2.57
14.55
10.4
5.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
85
352
2.85
14.54
3.4
2.4
e6/l
1.1
1.2
0.01
56
200
(36304419) Bacteria [Presence] in Urine
117
574
2.53
14.26
3.8
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
179
1083
2.29
13.38
9.6
8.2
e9/l
0.0
0.0
0.39
145
895
(3017143) Hepatitis C virus Ab [Presence] in Serum
91
408
2.64
13.25
1.8
1.8
—
—
—
0
0
(3026782) Osmolality of Urine
91
415
2.59
12.75
3.2
2.4
mosm/kgh2o
606.7
593.6
0.19
80
352
(3013826) Glucose [Moles/volume] in Serum or Plasma
218
1461
2.24
12.35
5.8
4.9
mmol/l
6.7
6.9
0.34
207
1378
(46235355) HIV 1 and 2 tests - Meaningful Use set
111
580
2.32
11.41
2.0
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
114
623
2.21
10.39
1.4
1.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
155
955
2.09
10.35
9.3
4.4
g/l
36.6
36.7
0.14
144
887
(3037467) Urinalysis macro (dipstick) panel - Urine
221
1559
2.07
10.11
4.3
3.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
174
1126
2.05
10.10
6.6
6.3
%
0.7
0.7
0.13
166
1076
(3006504) Eosinophils/100 leukocytes in Blood
177
1156
2.04
9.99
6.7
6.2
%
3.0
3.2
0.46
169
1099
(3019069) Monocytes/100 leukocytes in Blood
178
1167
2.03
9.91
7.2
6.5
%
8.8
9.0
0.27
169
1112
(3006315) Basophils [#/volume] in Blood
186
1240
2.03
9.87
6.5
6.3
e9/l
0.0
0.0
1.56
156
1111
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
162
1028
2.04
9.87
12.1
6.6
mmol/l
1.2
1.2
0.14
128
897
(3001604) Monocytes [#/volume] in Blood
185
1236
2.02
9.71
6.5
6.2
e9/l
0.6
0.6
0.61
155
1098
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
50
193
2.85
9.56
2.5
1.9
pmol/l
207.0
245.7
1.47
50
185
(3013115) Eosinophils [#/volume] in Blood
189
1280
2.00
9.47
6.7
6.6
e9/l
0.2
0.2
1.74
163
1150
(3044640) Blood type and Crossmatch panel - Blood
109
607
2.14
9.33
3.4
2.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
189
1286
1.98
9.28
6.4
6.3
e9/l
1.6
1.9
5.59
162
1158
(3002030) Lymphocytes/100 leukocytes in Blood
181
1215
1.98
9.22
6.8
6.2
%
26.6
28.1
1.12
173
1157
(3000850) Epithelial cells [#/volume] in Urine
85
433
2.26
9.06
2.9
2.2
e6/l
3.2
2.6
0.34
75
377
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
61
4.14
8.75
4.1
3.2
u/ml
0.3
0.3
0.31
12
33
(3032080) INR in Blood by Coagulation assay
143
914
1.93
8.16
11.8
9.3
inr
1.4
1.3
0.23
33
267
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
19
43
4.61
7.99
3.9
6.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
19
43
4.61
7.99
1.9
3.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
175
1207
1.87
7.82
6.6
5.9
%
58.8
56.7
1.70
167
1155
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
143
930
1.89
7.63
10.4
6.2
mmol/l
1.2
1.2
0.93
137
858
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
310
2609
2.31
7.42
19.6
9.3
ml/min/173m2
86.4
88.4
0.71
282
2135
(3023368) Bacteria identified in Blood by Culture
104
613
1.98
7.41
8.0
4.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
90
516
1.99
6.89
1.8
1.7
mg/l
1.3
1.0
0.42
71
370
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
46
209
2.38
6.30
3.4
2.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
20
57
3.66
6.25
1.4
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
6
15.33
5.93
1.0
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
80
467
1.92
5.73
3.2
2.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
46
3.83
5.71
1.6
1.4
ug/g
285.4
324.9
—
8
26
(3019550) Sodium [Moles/volume] in Serum or Plasma
318
2786
2.16
5.58
22.0
12.5
mmol/l
139.4
139.7
2.16
311
2714
(3049717) Cytology report of Urine Cyto stain
20
62
3.36
5.53
3.6
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
12
25
4.93
5.53
1.2
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
315
2762
2.08
5.32
19.8
10.6
mg/l
23.4
23.5
0.02
259
2107
(3023103) Potassium [Moles/volume] in Serum or Plasma
318
2803
2.11
5.21
22.3
12.5
mmol/l
4.0
4.0
0.28
310
2732
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
31
129
2.53
5.12
1.6
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
24
91
2.75
4.76
1.3
1.7
mu/l
228.7
258.9
0.38
24
85
(3041096) Erythrocytes [Presence] in Urine by Automated
100
660
1.71
4.70
3.1
2.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
90
579
1.74
4.63
8.1
3.5
ph
7.4
7.4
0.04
30
97
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
44
3.51
4.51
2.5
3.6
%
56.2
54.6
0.29
15
44
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
106
2.57
4.49
1.1
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
150
1110
1.60
4.47
3.3
2.8
estimate
0.0
0.0
0.49
31
195
(3009261) Glucose [Presence] in Urine by Test strip
151
1123
1.59
4.38
3.3
2.8
estimate
0.0
0.0
0.00
30
181
(3021601) Nitrite [Presence] in Urine by Test strip
149
1107
1.59
4.33
5.1
3.8
estimate
0.0
0.0
0.00
31
204
(3026008) Bacteria identified in Urine by Culture
57
331
1.86
4.10
3.6
2.4
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
42
3.43
4.08
2.6
3.5
e9/l
3.6
4.1
0.41
14
42
(3026493) Urate [Moles/volume] in Serum or Plasma
99
677
1.64
4.00
3.5
2.3
umol/l
366.0
8354.5
3.00
91
610
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
113
2.40
3.95
2.4
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
29
3.88
3.83
1.5
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
191
1538
1.51
3.68
3.9
3.2
ug/l
1.7
1.6
0.21
169
1398
(3019832) Treponema pallidum Ab [Presence] in Serum
38
201
1.99
3.60
2.0
1.8
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
7
9
7.90
3.57
3.7
1.1
u/l
176.0
175.3
—
7
9
(3000330) Specific gravity of Urine by Test strip
21
87
2.50
3.54
5.6
3.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
40
217
1.95
3.53
14.1
8.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
17
5.40
3.53
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
268
2331
1.58
3.52
25.8
12.6
%
13.5
13.3
1.02
263
2282
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
10
7.11
3.38
1.3
2.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
55
337
1.75
3.32
2.9
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
325
2984
1.87
3.31
19.4
9.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
47
275
1.81
3.31
4.8
2.4
%
24.6
25.6
0.22
41
236
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
33
3.41
3.22
2.8
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
331
3063
1.94
3.19
14.4
8.0
u/l
32.3
33.8
0.72
326
2975
(3012544) pH of Venous blood
42
240
1.85
3.19
6.5
3.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
40
227
1.86
3.10
4.2
2.4
u/l
27.9
248.9
0.54
34
196
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
141
2.07
3.04
1.8
1.4
—
—
—
0
0
(3019225) pH of Specimen
34
184
1.94
3.04
6.4
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
52
2.76
2.92
5.8
3.3
—
—
—
0
0
(4038314)
6
9
6.76
2.88
1.2
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
264
1.76
2.86
4.4
2.9
umol/l
8.9
10.4
0.18
37
235
(3002032) Base excess in Venous blood by calculation
40
235
1.79
2.79
6.8
3.0
mmol/l
1.1
1.7
0.52
33
190
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
72
2.43
2.77
1.1
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
40
236
1.78
2.75
6.8
3.0
kpa
5.9
5.8
0.04
40
229
(3022145) Colonoscopy Study observation
41
245
1.76
2.71
1.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
119
917
1.44
2.65
3.3
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
24
123
2.02
2.52
9.6
16.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
70
2.35
2.45
3.4
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
16
71
2.31
2.38
1.1
1.2
u/ml
325.1
280.2
0.25
11
47
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
102
782
1.42
2.30
3.3
2.6
u/l
54.7
59.1
0.70
93
742
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
24
128
1.94
2.27
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
18
3.94
2.26
1.3
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
80
2.18
2.22
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
9
5.61
2.22
1.8
11.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
42
2.67
2.20
1.5
1.5
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
7
20
3.55
2.06
1.3
1.5
nmol/l
0.2
0.2
—
7
15
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
19
98
1.99
1.99
2.7
2.8
pmol/l
4.7
4.7
0.03
14
87
(3023520) Reticulocytes [#/volume] in Blood
28
165
1.76
1.97
3.6
2.4
e9/l
68.3
68.0
0.01
19
126
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
21
3.38
1.97
2.0
1.9
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
11
4.59
1.94
1.2
1.4
mg/l
4.7
2.6
—
5
11
(3042936) Bacteria identified in Isolate by Culture
52
361
1.51
1.93
2.1
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
624
1.41
1.91
2.9
3.1
ng/l
991.5
1242.0
0.41
70
509
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
28
2.90
1.87
2.5
2.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
28
2.90
1.87
1.3
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
46
2.43
1.87
2.8
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
46
2.43
1.87
2.8
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
131
1.81
1.82
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
47
2.38
1.79
1.5
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
88
1.98
1.78
3.1
3.6
g/l
0.1
0.2
—
9
42
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
187
1.66
1.75
2.5
2.0
ml/min/173m2
68.6
69.0
0.01
16
71
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
18
3.37
1.75
4.8
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
120
983
1.33
1.75
3.7
3.2
ng/l
70.2
56.3
0.15
84
638
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
246
2673
0.75
1.73
4.3
3.9
mmol/l
6.0
6.0
0.04
223
2473
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
13
3.88
1.72
1.2
1.9
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
13
3.88
1.72
1.4
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
42
2.42
1.69
1.1
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
17
90
1.93
1.68
5.2
9.9
%
2.6
0.9
0.50
17
85
(3035637) Corticotropin [Mass/volume] in Plasma
6
19
3.19
1.67
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
19
3.19
1.67
3.2
3.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
62
461
1.42
1.64
2.5
2.0
mg/l
3.0
2.9
0.02
53
395
(3007461) Platelets [#/volume] in Blood
340
3261
1.70
1.64
30.7
14.9
e9/l
231.4
238.8
1.62
335
3182
(3051651) Icteric interference index of Serum or Plasma
5
14
3.61
1.62
14.0
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
204
1811
1.29
1.60
3.9
3.6
mm/h
12.8
9.0
2.09
187
1693
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
26
2.72
1.59
1.0
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
340
3265
1.68
1.57
30.6
14.8
pg
30.2
30.4
2.13
335
3218
(3013512) EKG study
84
662
1.35
1.57
5.2
3.5
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
340
3266
1.68
1.56
30.8
14.9
e12/l
4.7
4.8
4.66
334
3178
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
64
2.07
1.56
2.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
15
3.36
1.53
1.0
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
51
2.19
1.52
6.2
3.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
340
3269
1.66
1.51
30.8
15.0
e9/l
6.2
6.7
5.05
335
3184
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
271
2888
0.75
1.48
4.1
4.0
mmol/l
1.3
1.3
0.13
253
2726
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
276
2932
0.75
1.46
4.4
4.4
mmol/l
2.9
2.8
0.06
261
2760
(3019309) Folate [Moles/volume] in Red Blood Cells
49
359
1.42
1.42
1.9
1.8
nmol/l
1014.9
1205.8
0.96
35
294
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
46
2.21
1.41
1.7
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
41
2.22
1.38
1.8
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
41
2.22
1.38
1.8
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
23
2.63
1.37
3.8
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
35
242
1.49
1.36
2.9
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
17
2.97
1.36
14.0
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
42
2.17
1.34
5.6
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
29
193
1.55
1.34
2.9
2.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
24
2.52
1.31
1.0
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
29
195
1.53
1.29
6.3
2.4
kpa
6.0
4.6
1.84
29
188
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
18
2.80
1.29
2.4
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
5
18
2.80
1.29
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
25
371
0.65
1.27
1.2
1.2
iu/ml
13.2
26.7
—
8
110
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
35
248
1.46
1.22
2.9
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
2.4
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
2.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
2.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
19
2.65
1.22
2.4
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
19
2.65
1.22
2.4
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
3.8
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
26
2.33
1.19
1.0
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
274
2894
0.78
1.19
4.2
4.1
mmol/l
4.7
4.6
0.32
257
2739
(3000492) Spirometry study
46
346
1.38
1.17
2.0
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
40
2.02
1.12
1.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
31
2.28
1.11
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
41
306
1.38
1.10
2.1
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
204
1860
1.22
1.10
3.5
3.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
73
595
1.28
1.08
5.0
4.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
22
2.29
1.03
1.8
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
101
862
1.24
1.02
2.5
2.2
ug/l
0.7
0.7
0.00
67
472
(3011288) Drugs identified in Urine by Screen method
9
158
0.56
1.01
1.4
5.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(4027681)
5
23
2.19
0.98
1.0
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
30
0.00
0.97
0.0
1.4
—
350.0
—
0
5
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
36
1.96
0.97
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
183
1.45
0.97
3.2
4.9
%
0.4
0.0
—
5
38
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
15
93
1.64
0.95
5.5
9.6
%
1.9
1.6
0.19
15
87
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
51
1.78
0.95
1.8
1.3
—
1.1
—
0
7
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
37
1.91
0.94
1.0
1.1
—
—
—
0
0
(4268621)
6
27
2.24
0.94
3.7
2.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
39
298
1.35
0.92
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
28
202
1.42
0.92
3.6
4.7
%
1.7
0.7
—
6
49
(3035285) Chloride [Moles/volume] in Venous blood
6
28
2.16
0.92
2.7
2.0
mmol/l
105.2
105.5
—
6
28
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
28
2.16
0.92
1.0
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
28
2.16
0.92
2.7
2.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
28
2.16
0.92
2.7
2.0
mmol/l
4.3
4.1
—
6
28
(3003396) Base excess in Arterial blood by calculation
36
272
1.36
0.91
12.8
10.3
mmol/l
0.5
1.3
0.68
29
214
(3021440) Promyelocytes/100 leukocytes in Blood
27
194
1.42
0.91
3.2
4.8
%
0.0
0.1
—
6
45
(3002173) Hemoglobin [Mass/volume] in Arterial blood
31
229
1.39
0.90
14.1
11.6
g/l
118.5
127.9
1.64
31
221
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
6
29
2.09
0.89
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
29
2.09
0.89
2.5
4.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
29
2.09
0.89
1.5
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
29
2.09
0.89
1.7
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
95
1.60
0.89
2.7
2.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
292
1.34
0.87
3.7
4.2
%
29.4
29.2
0.03
29
218
(3015235) Bicarbonate [Moles/volume] in Capillary blood
11
64
1.74
0.87
5.6
2.1
mmol/l
25.2
23.8
0.68
11
58
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
46
573
0.77
0.86
1.4
1.2
u/ml
7.1
1.1
0.60
14
186
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
178
0.61
0.85
1.5
1.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
45
1.80
0.85
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
31
1.95
0.84
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
121
1.51
0.84
3.3
3.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
267
2797
0.83
0.83
3.8
3.7
mmol/l
1.5
1.4
0.61
250
2636
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
73
1.67
0.82
1.3
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
32
1.89
0.82
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
102
891
1.20
0.82
4.0
2.4
ug/l
203.1
164.1
0.96
92
829
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
33
1.83
0.79
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
74
1.64
0.79
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
74
1.64
0.79
1.3
1.1
—
—
—
0
0
(4146454)
0
26
0.00
0.78
0.0
3.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
19
132
1.46
0.77
1.9
1.9
g/l
64.5
67.8
1.03
19
117
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
53
1.72
0.76
1.8
1.3
g/l
9.6
10.9
—
9
43
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
100
879
1.19
0.75
1.8
1.8
pmol/l
95.4
93.3
0.17
59
500
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
108
1.50
0.75
3.3
2.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
17
241
0.69
0.74
1.2
3.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
38
1.86
0.74
1.3
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
17
240
0.69
0.73
1.2
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
374
1.26
0.72
1.9
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
40
1.76
0.71
1.0
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
26
1.94
0.71
2.4
3.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
477
1.23
0.70
3.3
2.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
41
1.72
0.70
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
41
1.72
0.70
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
17
238
0.70
0.70
1.2
3.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
59
1.54
0.69
3.8
2.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
28
1.80
0.66
4.6
1.9
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
28
1.80
0.66
1.0
1.2
mg/l
60.4
46.3
—
5
22
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
2.0
1.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
128
0.62
0.65
1.0
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
77
878
0.84
0.64
3.1
3.8
mmol/l
8.8
9.3
0.41
61
760
(3027944) Amphetamines [Presence] in Urine
17
233
0.72
0.63
1.2
3.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
63
1.60
0.62
1.6
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
30
1.68
0.61
1.2
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
16
220
0.71
0.61
1.3
3.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
448
1.21
0.61
1.5
1.4
nmol/l
18.2
19.3
0.25
47
388
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
8
51
1.58
0.61
1.8
1.3
g/l
0.1
0.4
—
8
44
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
2.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
244
2549
0.87
0.59
6.1
5.3
mmol/mol
39.5
40.0
0.30
222
2417
(3052851) Hemolysis interference index of Serum or Plasma
10
64
1.58
0.59
13.1
2.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
7
114
0.61
0.59
1.4
1.8
—
244.0
—
0
5
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
414
1.21
0.57
1.9
2.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
89
0.56
0.56
1.4
1.4
—
95.0
—
0
10
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
37
1.63
0.56
8.0
4.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
6
38
1.59
0.54
1.7
3.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
75
1.48
0.51
1.1
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
7
48
1.47
0.47
1.9
1.3
g/l
36.0
39.2
—
7
36
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
81
0.61
0.46
1.0
1.0
—
3.4
—
0
13
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
86
1.41
0.45
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
130
1208
1.12
0.45
3.0
3.1
%
22.8
23.7
0.28
57
451
(3003327) Ova and parasites identified in Stool by Light microscopy
11
78
1.42
0.43
1.1
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
8
56
1.44
0.43
1.6
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
8
56
1.44
0.43
1.0
1.1
—
99.4
—
0
16
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34
287
1.20
0.42
6.6
6.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
118
1268
0.90
0.41
2.8
2.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
183
0.76
0.41
1.2
3.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.2
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
0.5
—
0
5
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.3
—
1.3
—
0
11
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
101
0.69
0.40
1.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
7
104
0.67
0.40
1.4
5.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
115
1.32
0.39
3.3
2.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
0.4
—
0
13
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
22
179
1.24
0.38
2.6
3.2
ng/l
86.5
174.3
1.47
22
159
(3008898) HLA-B27 [Presence]
8
113
0.70
0.37
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
8
115
0.69
0.37
3.4
4.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
9
69
1.31
0.37
7.2
12.7
mmol/l
1.2
1.3
—
9
61
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
207
2153
0.91
0.37
3.3
3.1
u/l
54.8
48.8
0.39
196
2051
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
70
1.29
0.37
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
41
1.47
0.36
1.0
1.1
—
—
—
0
0
(4094501)
5
77
0.64
0.36
1.0
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
108
1.31
0.36
3.1
3.6
mmol/l
22.8
24.9
1.36
14
101
(3001019) Free T4 and TSH panel - Serum or Plasma
9
126
0.71
0.35
1.1
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
454
1.14
0.35
1.6
1.8
pmol/l
402.9
9975475.5
0.50
40
401
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
62
683
0.89
0.34
1.8
1.7
mmol/l
1.6
1.6
0.03
49
587
(3004588) Protein electrophoresis panel - Serum or Plasma
14
109
1.30
0.34
1.8
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
6
46
1.31
0.33
4.2
2.3
g/l
1.1
1.2
—
6
37
(3044290) Cell count panel - Cerebral spinal fluid
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
93
866
1.10
0.31
2.9
2.2
nmol/l
73.0
72.0
0.13
85
793
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
(3010421) pH of Blood
7
57
1.23
0.29
6.9
3.6
ph
7.4
7.4
—
7
42
(3007164) IgA [Mass/volume] in Serum or Plasma
45
500
0.89
0.29
1.3
1.3
g/l
2.3
2.6
0.95
30
345
(3029937) Albumin [Presence] in Urine by Test strip
64
587
1.11
0.28
3.2
3.0
estimate
0.0
0.0
0.68
29
192
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
62
1.30
0.28
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
283
2773
1.09
0.27
24.6
10.8
%
40.8
42.7
2.78
225
2195
(36660697) Celiac disease serology panel - Serum
17
202
0.83
0.25
1.3
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
74
1.22
0.25
1.1
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
75
1.21
0.25
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
49
536
0.90
0.25
3.1
3.1
kg/l
1.0
1.0
—
10
65
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
12
96
1.26
0.25
3.8
2.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
13
158
0.82
0.24
8.5
10.0
mmol/l
24.0
24.2
0.09
13
149
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
210
2040
1.07
0.24
2.8
3.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
20.0
—
0
10
(4015189)
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
34
307
1.12
0.21
1.8
1.6
—
—
—
0
0
(1002224) Polysomnography panel
16
187
0.85
0.20
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
8.0
—
0
5
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
82
1.23
0.17
1.9
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
71
1.13
0.16
3.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
75
788
0.94
0.16
4.1
4.4
mg/mmol
10.4
9.8
0.05
49
554
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
69
727
0.94
0.16
2.6
2.1
u/l
127.0
264.9
3.47
69
687
(3005719) IgG [Mass/volume] in Serum or Plasma
18
203
0.88
0.15
2.2
2.4
g/l
10.1
11.0
0.67
18
181
(40768443) Skin Pathology biopsy report
9
78
1.16
0.15
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
14
121
1.16
0.15
1.3
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
192
0.88
0.15
3.2
2.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
397
0.92
0.14
1.8
1.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
71
741
0.95
0.12
3.2
3.6
mg/l
52.6
152.0
0.65
49
513
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
268
0.93
0.09
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
13
144
0.90
0.08
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
88
1.02
0.07
3.0
4.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
227
2292
0.97
0.06
4.1
3.3
mu/l
1.9
2.4
0.41
203
2119
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
179
1768
1.02
0.06
3.7
2.7
pmol/l
15.0
14.9
0.13
162
1620
(3019060) Gas panel - Arterial blood
16
170
0.94
0.04
6.0
7.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
55
538
1.03
0.03
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
41
401
1.03
0.02
1.3
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
47
479
0.98
0.02
1.2
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
12
127
0.94
0.01
1.2
1.6
—
10.3
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
124
1.05
0.00
1.1
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
154
1.04
0.00
1.3
1.6
g/l
1.2
1.1
0.22
16
141
(4010399)
18
181
0.99
0.00
1.2
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
50
495
1.01
0.00
3.7
3.5
ng/l
286.4
1057.4
1.54
39
365
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
9
0.00
0.00
0.0
8.6
—
25.6
—
0
9
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
3.3
—
115.9
—
0
8
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
7
0.00
0.00
0.0
1.3
—
1.3
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.2
—
1.1
—
0
6
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
17.7
—
0
6
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
4.0
—
3.8
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.2
—
52.6
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
11.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
83
0.96
0.00
2.9
2.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(44806420)
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
160
1.00
0.00
1.3
1.3
—
44.8
—
0
11
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
260
1.00
0.00
1.7
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
0
8
0.00
0.00
0.0
3.0
—
25.8
—
0
8
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
1.6
—
14.6
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
35.7
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
3.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS_SEMINOMA_EXALLC – Seminoma of testis, excluding all cancers (controls excluding all cancers)

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).